Skip to content
Wearables & measurementValidation study/review3 min read

Fitbit overestimated sitting time by about an hour a day in older heart patients

MoveVitals Editorial Collective · Study published · Reading updated

Original paper:Assessment of Wrist-Worn Activity Tracker Accuracy for Measuring Sedentary Behavior in Outpatients With Cardiovascular Disease: Validation Study. · JMIR cardio · 2026 · Original paper ↗

Key takeaway

In 51 Japanese outpatients with heart failure or ischemic heart disease (mean age 78.4), a Fitbit Inspire 3 overestimated sedentary time by 62.0 minutes (95% CI 51.5-72.5) in a 12-hour daytime window compared with a waist-worn research accelerometer. The two devices tracked each other well in a group (r = 0.905), but individual limits of agreement were wide (-11.3 to 135.2 minutes).

Study design

Validation study/review

Reading basis

Published abstract

Reading focus

Reference & error

The research question

Doctors increasingly use wearables to monitor how much heart patients sit, yet consumer wrist trackers have not been checked in older patients with cardiac problems. The authors measured how well a Fitbit agrees with a research-grade accelerometer in daily life.

Who and how

Validation study of 51 outpatients (28 with heart failure, 23 with ischemic heart disease; mean age 78.4, SD 9.0 years; 25 men) who wore a wrist-worn Fitbit Inspire 3 and a waist-worn Omron ActiveStyle Pro HJA-750C comparator for 7 consecutive days. Sedentary time was compared within a standardized 12-hour window (9 AM to 9 PM) in 1-minute epochs. Agreement was assessed by Pearson correlation, Bland-Altman analysis, Lin concordance correlation coefficient (CCC) and Cohen kappa for tertiles. A constant bias correction was tested with leave-one-out cross-validation, and moderators of the bias with multivariable regression.

What it found

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Mean sedentary time in the window was 497.9 (SD 86.5) minutes for the comparator and 559.9 (SD 84.3) minutes for the Fitbit, with a strong correlation (r = 0.905, 95% CI 0.838-0.945; P < .001).
  2. 2
    The Fitbit had a fixed bias of 62.0 minutes (95% CI 51.5-72.5; P < .001) and no proportional bias (slope -0.03; P = .67); the 95% limits of agreement were wide (-11.3 to 135.2 minutes).
  3. 3
    Concordance was moderate before correction (CCC 0.71, 95% CI 0.57-0.80) and high after subtracting 62 minutes (CCC 0.904, 95% CI 0.84-0.94); cross-validated CCC was 0.90.
  4. 4
    No factor (sex, age, diagnosis, musculoskeletal disorder) significantly moderated the bias (model P = .12).
  5. 5
    Sorting people into tertiles gave moderate agreement (kappa 0.588, 95% CI 0.405-0.772; 37 of 51, 72.5%), with all misclassifications falling in adjacent categories.

Limits & uncertainty

  1. 1
    Only 51 older Japanese outpatients were studied, so the results may not hold in other populations or devices.
  2. 2
    The comparator was a waist-worn accelerometer, not direct observation, so it is itself an estimate.
  3. 3
    The 62-minute correction was derived in this sample and needs independent validation, as the authors state.
  4. 4
    Wide limits of agreement mean individual-level precision is limited, and only a 12-hour daytime window was analysed.

What to take from it

A wrist tracker like this one can show a person's relative sitting pattern, but its absolute sitting minutes ran high in this group. The correction seems to work only for group-level monitoring and should not be applied to your own data. Health decisions belong with a clinician.

Reading your own data

If your wearable reports sedentary or inactive time, expect it to differ from other devices by a fixed offset and compare only against your own earlier readings on the same device. Watching weekly trends is more reliable than any single day's total.

How to read this evidence

Agreement is specific to the device, firmware, reference, population and setting. Correlation is not agreement, and validating a metric is not proof of diagnostic or treatment benefit.

Authors’ structured abstract English

The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.

Background

Wearable monitoring of sedentary behavior is increasingly used in digital cardiovascular care, but the validity of consumer-grade wrist-worn trackers in older patients with cardiac issues is unclear.

Objective

This study aimed to evaluate the agreement between sedentary time measured by a consumer-grade wrist-worn tracker (Fitbit Inspire 3; Fitbit LLC) and a research-grade waist-worn accelerometer (ActiveStyle Pro HJA-750C; Omron Healthcare Co, Ltd) used as the comparator, in Japanese outpatients with cardiac issues under free-living conditions.

Methods

Fifty-one outpatients with heart failure (28/51, 55%) or ischemic heart disease (23/51, 45%; mean age 78.4, SD 9.0 years; 25/51, 49% male) simultaneously wore both devices for 7 consecutive days. Sedentary time was assessed within a standardized 12-hour daytime window (9 AM to 9 PM) at 1-minute epochs. Agreement was examined using Pearson correlation, Bland-Altman analysis (after confirming normality of the paired differences), Lin concordance correlation coefficient (CCC), and Cohen kappa for distribution-based tertile classification. A constant bias correction was applied, with leave-one-out cross-validation (LOOCV) used as an internal-consistency check on the stability of the sample mean bias. Moderators of the bias were explored using multivariable regression.

Results

Mean sedentary time within the 12-hour window was 497.9 (SD 86.5) minutes for the comparator and 559.9 (SD 84.3) minutes for the Fitbit. The devices were strongly correlated ( r =0.905, 95% CI 0.838-0.945; P <.001). The Fitbit showed a significant fixed bias of 62.0 minutes (95% CI 51.5-72.5; P <.001) with no proportional bias (slope -0.03; P =.67); the 95% limits of agreement were wide (-11.3 to 135.2 minutes). Uncorrected concordance was moderate (CCC=0.71, 95% CI 0.57-0.80) and improved to high after subtracting the 62-minute bias (CCC=0.904, 95% CI 0.84-0.94); LOOCV indicated that this in-sample improvement was internally stable (out-of-sample CCC=0.90). No candidate factor (sex, age, diagnosis, and musculoskeletal disorder) significantly moderated the bias (model P =.12). Tertile classification showed moderate agreement (κ=0.588, 95% CI 0.405-0.772; 37/51, 72.5% agreement), with all misclassifications between adjacent categories.

Conclusions

In older Japanese outpatients with cardiac issues, a consumer-grade wrist-worn tracker overestimated sedentary time by approximately 62 minutes within a standardized 12-hour daytime window compared with a waist-worn comparator, with fixed but no proportional bias. A simple constant correction markedly improved group-level concordance (cross-validated CCC≈0.90), supporting calibrated use of consumer wearables for scalable monitoring in ambulatory cardiac care. However, wide limits of agreement constrain individual-level precision, and the population-specific correction factor requires independent validation before transfer to other settings.

Sources & attribution

Assessment of Wrist-Worn Activity Tracker Accuracy for Measuring Sedentary Behavior in Outpatients With Cardiovascular Disease: Validation Study.

Naito K, Izawa KP, Maeda N, Kasai Y, Tani H, Kondo M, Iwama H.

JMIR cardio · 2026-09-30

DOI: 10.2196/91104 ↗PubMed · 42814647 ↗Europe PMC · Recorded licence: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

MoveVitals editorial interpretation · educational content · no individual clinical review recorded

Sources checked 2026-11-01

Practical guides

Read in context

·Cohort study

Activity–stroke and heart attack curves differ by accelerometer processing method

Among 90,237 UK Biobank adults free of cardiovascular disease at baseline, followed until December 2022 for 1,298 strokes and 2,031 myocardial infarctions, the shape of the link between moderate-vigorous physical activity (MVPA) and each outcome depended on how the accelerometer data were processed. For stroke, hazard fell in a straight line only with the machine-learning metric; for myocardial infarction, two metrics gave a curved decline and activity counts a straight one. The abstract gives no hazard ratios, so it shows that methods disagree, not which one is right, and the findings are observational associations.

Preventive Medicine

In-depth explainersRead study →
·Validation study/review

Smartwatch data as forensic evidence: heart rate is best validated, the rest uneven

A systematic review and meta-analysis of studies on smartwatches from four major brands, framed around digital forensics, found that heart rate was both the most studied and the most accurate measure. Step count, distance, energy expenditure, activity classification and sleep were less consistently validated, and results varied by brand, protocol and reporting. The abstract gives no pooled numbers, and most studies were run in healthy people in laboratories, so it cannot say how a particular watch performs for a particular person in daily life.

Forensic Science International

In-depth explainersRead study →
·Overview of reviews

Activity trackers: about 1,800 more steps a day, but small effects on other outcomes

An umbrella review of 39 systematic reviews and meta-analyses, covering 163,992 participants, found that activity trackers were associated with more physical activity (SMD 0.3–0.6), equating to about 1,800 extra steps and 40 minutes more walking per day, and with a bodyweight reduction of about 1 kg. Effects on blood pressure, cholesterol, glycosylated haemoglobin, quality of life and pain were typically small and often non-significant. The abstract does not say what else came with the trackers in these programs or how much the reviews overlap, so the gains cannot be credited to the device alone.

The Lancet Digital Health

In-depth explainersRead study →
·Validation study/review

Seven sleep trackers: good at spotting sleep, weak on wake and sleep stages

In a sleep laboratory, 34 healthy young adults wore a subset of seven consumer sleep trackers for three nights. Against polysomnography every device detected sleep very well (sensitivity 0.93 or higher) but caught wake poorly (specificity 0.18–0.54), and five of the seven matched or beat research actigraphy (specificity 0.39). Sleep-stage estimates were inconsistent, and the participants were healthy adults aged 18 to 35 in a fixed 8-hour bed window, with each device tested in only 11 to 20 of them, so the results say little about people with sleep problems.

Sleep

In-depth explainersRead study →
Wearables & measurement →